183 related articles for article (PubMed ID: 23741348)
1. Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.
Venkatesh KK; Becker JE; Kumarasamy N; Nakamura YM; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP; Freedberg KA
PLoS One; 2013; 8(5):e64604. PubMed ID: 23741348
[TBL] [Abstract][Full Text] [Related]
2. Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness.
Bassett IV; Govindasamy D; Erlwanger AS; Hyle EP; Kranzer K; van Schaik N; Noubary F; Paltiel AD; Wood R; Walensky RP; Losina E; Bekker LG; Freedberg KA
PLoS One; 2014; 9(1):e85197. PubMed ID: 24465503
[TBL] [Abstract][Full Text] [Related]
3. Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis.
Dunning L; Gandhi AR; Penazzato M; Soeteman DI; Revill P; Frank S; Phillips A; Dugdale C; Abrams E; Weinstein MC; Newell ML; Collins IJ; Doherty M; Vojnov L; Fassinou Ekouévi P; Myer L; Mushavi A; Freedberg KA; Ciaranello AL
J Int AIDS Soc; 2021 Jan; 24(1):e25651. PubMed ID: 33474817
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
Freedberg KA; Kumarasamy N; Losina E; Cecelia AJ; Scott CA; Divi N; Flanigan TP; Lu Z; Weinstein MC; Wang B; Ganesh AK; Bender MA; Mayer KH; Walensky RP
AIDS; 2007 Jul; 21 Suppl 4(Suppl 4):S117-28. PubMed ID: 17620747
[TBL] [Abstract][Full Text] [Related]
5. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
[TBL] [Abstract][Full Text] [Related]
6. Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
Luong Nguyen LB; Yazdanpanah Y; Maman D; Wanjala S; Vandenbulcke A; Price J; Parker RA; Hennequin W; Mendiharat P; Freedberg KA
Clin Infect Dis; 2018 Aug; 67(5):719-726. PubMed ID: 29746619
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.
Reddy KP; Gupta-Wright A; Fielding KL; Costantini S; Zheng A; Corbett EL; Yu L; van Oosterhout JJ; Resch SC; Wilson DP; Horsburgh CR; Wood R; Alufandika-Moyo M; Peters JA; Freedberg KA; Lawn SD; Walensky RP
Lancet Glob Health; 2019 Feb; 7(2):e200-e208. PubMed ID: 30683239
[TBL] [Abstract][Full Text] [Related]
8. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
[TBL] [Abstract][Full Text] [Related]
9. The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa.
Walensky RP; Wood R; Fofana MO; Martinson NA; Losina E; April MD; Bassett IV; Morris BL; Freedberg KA; Paltiel AD;
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):26-35. PubMed ID: 21068674
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.
Ouattara EN; MacLean RL; Danel C; Borre ED; Gabillard D; Huang M; Moh R; Paltiel AD; Eholié SP; Walensky RP; Anglaret X; Freedberg KA
PLoS One; 2019; 14(6):e0219068. PubMed ID: 31247009
[TBL] [Abstract][Full Text] [Related]
11. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.
Uhler LM; Kumarasamy N; Mayer KH; Saxena A; Losina E; Muniyandi M; Stoler AW; Lu Z; Walensky RP; Flanigan TP; Bender MA; Freedberg KA; Swaminathan S;
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862279
[TBL] [Abstract][Full Text] [Related]
13. The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India.
Kazemian P; Costantini S; Kumarasamy N; Paltiel AD; Mayer KH; Chandhiok N; Walensky RP; Freedberg KA
Clin Infect Dis; 2020 Feb; 70(4):633-642. PubMed ID: 30921454
[TBL] [Abstract][Full Text] [Related]
14. Routine HIV screening in Portugal: clinical impact and cost-effectiveness.
Yazdanpanah Y; Perelman J; DiLorenzo MA; Alves J; Barros H; Mateus C; Pereira J; Mansinho K; Robine M; Park JE; Ross EL; Losina E; Walensky RP; Noubary F; Freedberg KA; Paltiel AD
PLoS One; 2013; 8(12):e84173. PubMed ID: 24367639
[TBL] [Abstract][Full Text] [Related]
15. Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.
Freedberg KA; Kumarasamy N; Borre ED; Ross EL; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP
AIDS Res Hum Retroviruses; 2018 Jun; 34(6):486-497. PubMed ID: 29620932
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.
Luz PM; Osher B; Grinsztejn B; Maclean RL; Losina E; Stern ME; Struchiner CJ; Parker RA; Freedberg KA; Mesquita F; Walensky RP; Veloso VG; Paltiel AD
J Int AIDS Soc; 2018 Mar; 21(3):e25096. PubMed ID: 29603888
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.
Ciaranello AL; Doherty K; Penazzato M; Lindsey JC; Harrison L; Kelly K; Walensky RP; Essajee S; Losina E; Muhe L; Wools-Kaloustian K; Ayaya S; Weinstein MC; Palumbo P; Freedberg KA
AIDS; 2015 Jun; 29(10):1247-59. PubMed ID: 25870982
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti.
Koenig SP; Bang H; Severe P; Jean Juste MA; Ambroise A; Edwards A; Hippolyte J; Fitzgerald DW; McGreevy J; Riviere C; Marcelin S; Secours R; Johnson WD; Pape JW; Schackman BR
PLoS Med; 2011 Sep; 8(9):e1001095. PubMed ID: 21949643
[TBL] [Abstract][Full Text] [Related]
19. Routine HIV screening in France: clinical impact and cost-effectiveness.
Yazdanpanah Y; Sloan CE; Charlois-Ou C; Le Vu S; Semaille C; Costagliola D; Pillonel J; Poullié AI; Scemama O; Deuffic-Burban S; Losina E; Walensky RP; Freedberg KA; Paltiel AD
PLoS One; 2010 Oct; 5(10):e13132. PubMed ID: 20976112
[TBL] [Abstract][Full Text] [Related]
20. The impact and cost-effectiveness of community-based HIV self-testing in sub-Saharan Africa: a health economic and modelling analysis.
Cambiano V; Johnson CC; Hatzold K; Terris-Prestholt F; Maheswaran H; Thirumurthy H; Figueroa C; Cowan FM; Sibanda EL; Ncube G; Revill P; Baggaley RC; Corbett EL; Phillips A;
J Int AIDS Soc; 2019 Mar; 22 Suppl 1(Suppl Suppl 1):e25243. PubMed ID: 30907498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
